157 related articles for article (PubMed ID: 1591842)
1. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions.
de Graaf JC; Banga JD; Moncada S; Palmer RM; de Groot PG; Sixma JJ
Circulation; 1992 Jun; 85(6):2284-90. PubMed ID: 1591842
[TBL] [Abstract][Full Text] [Related]
2. Endothelium-derived relaxing factor inhibits platelet adhesion to cultured porcine endocardial endothelium.
Siney L; Lewis MJ
Eur J Pharmacol; 1992 Dec; 229(2-3):223-6. PubMed ID: 1283374
[TBL] [Abstract][Full Text] [Related]
3. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide.
Radomski MW; Vallance P; Whitley G; Foxwell N; Moncada S
Cardiovasc Res; 1993 Jul; 27(7):1380-2. PubMed ID: 7504587
[TBL] [Abstract][Full Text] [Related]
4. Aprotinin inhibits platelet adhesion to endothelial cells.
Royston BD; Royston D; Pearson JD
Blood Coagul Fibrinolysis; 1992 Dec; 3(6):737-42. PubMed ID: 1283343
[TBL] [Abstract][Full Text] [Related]
5. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells.
McCall TB; Feelisch M; Palmer RM; Moncada S
Br J Pharmacol; 1991 Jan; 102(1):234-8. PubMed ID: 1710525
[TBL] [Abstract][Full Text] [Related]
6. Endogenous endothelium-derived relaxing factor inhibits platelet adhesion under whole blood flow conditions ex vivo.
Jen CJ; Chen CT; Chen H
Chin J Physiol; 1995; 38(3):147-51. PubMed ID: 8846723
[TBL] [Abstract][Full Text] [Related]
7. NG-monomethyl-L-arginine increases platelet deposition on damaged endothelium in vivo. A scanning electron microscopic study.
Herbaczyńska-Cedro K; Lembowicz K; Pytel B
Thromb Res; 1991 Oct; 64(1):1-9. PubMed ID: 1723225
[TBL] [Abstract][Full Text] [Related]
8. The effect of methylmercury (CH3HgCl) on the production of endothelium-derived relaxing factor (EDRF) by cultured human umbilical vascular endothelial cells based on its anti-aggregatory effect on human platelets.
Ohno M; Kishimoto T; Tada M
Cell Biol Toxicol; 1995 Dec; 11(6):303-11. PubMed ID: 8788207
[TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide synthesis in the regulation of coronary vascular tone in the isolated perfused rabbit heart.
Smith RE; Palmer RM; Bucknall CA; Moncada S
Cardiovasc Res; 1992 May; 26(5):508-12. PubMed ID: 1446321
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the L-arginine:nitric oxide pathway in human platelets.
Radomski MW; Palmer RM; Moncada S
Br J Pharmacol; 1990 Oct; 101(2):325-8. PubMed ID: 1701676
[TBL] [Abstract][Full Text] [Related]
11. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.
Rees DD; Palmer RM; Schulz R; Hodson HF; Moncada S
Br J Pharmacol; 1990 Nov; 101(3):746-52. PubMed ID: 1706208
[TBL] [Abstract][Full Text] [Related]
12. Role of endothelium-derived nitric oxide in the bleeding tendency of uremia.
Remuzzi G; Perico N; Zoja C; Corna D; Macconi D; Viganò G
J Clin Invest; 1990 Nov; 86(5):1768-71. PubMed ID: 2243146
[TBL] [Abstract][Full Text] [Related]
13. Roles of prostacyclin, EDRF and active oxygens in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro.
Hirafuji M; Shinoda H
Br J Pharmacol; 1993 Jun; 109(2):524-9. PubMed ID: 8358552
[TBL] [Abstract][Full Text] [Related]
14. Effects of guanidino compounds on the endothelium-derived relaxing factor inhibitor NG-monomethyl L-arginine.
Thomas G; Ramwell PW
J Pharmacol Exp Ther; 1991 Nov; 259(2):490-4. PubMed ID: 1719191
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological reactivity of human epicardial coronary arteries: characterization of relaxation responses to endothelium-derived relaxing factor.
Stork AP; Cocks TM
Br J Pharmacol; 1994 Dec; 113(4):1099-104. PubMed ID: 7889260
[TBL] [Abstract][Full Text] [Related]
16. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries.
Yao SK; Ober JC; Krishnaswami A; Ferguson JJ; Anderson HV; Golino P; Buja LM; Willerson JT
Circulation; 1992 Oct; 86(4):1302-9. PubMed ID: 1394936
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: blockade of aggregation and secretion by an aspirin-insensitive mechanism.
Broekman MJ; Eiroa AM; Marcus AJ
Blood; 1991 Aug; 78(4):1033-40. PubMed ID: 1868238
[TBL] [Abstract][Full Text] [Related]
18. Platelet cGMP, but not cAMP, inhibits thrombin-induced platelet adhesion to pulmonary vascular endothelium.
Venturini CM; Weston LK; Kaplan JE
Am J Physiol; 1992 Aug; 263(2 Pt 2):H606-12. PubMed ID: 1324614
[TBL] [Abstract][Full Text] [Related]
19. Agents that modify EDRF formation alter antiplatelet properties of brain arteriolar endothelium in vivo.
Nishimura H; Rosenblum WI; Nelson GH; Boynton S
Am J Physiol; 1991 Jul; 261(1 Pt 2):H15-21. PubMed ID: 1858916
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of L-N5-(1-iminoethyl)-ornithine on tone and endothelium-dependent vasodilator responses.
DeWitt BJ; Champion HC; Marrone JR; McNamara DB; Giles TD; Greenberg SS; Kadowitz PJ
Am J Physiol; 1997 Sep; 273(3 Pt 1):L588-94. PubMed ID: 9316493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
